Cargando…

Plasmodium falciparum Merozoite Surface Proteins Polymorphisms and Treatment Outcomes among Patients with Uncomplicated Malaria in Mwanza, Tanzania

BACKGROUND: The severity of malaria infection depends on the host, parasite and environmental factors. Merozoite surface protein (msp) diversity determines transmission dynamics, P. falciparum immunity evasion, and pathogenesis or virulence. There is limited updated information on P. falciparum msp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Marwa, Karol J., Lyimo, Eric, Konje, Eveline T., Kapesa, Anthony, Kamugisha, Erasmus, Swedberg, Göte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712017/ https://www.ncbi.nlm.nih.gov/pubmed/36467715 http://dx.doi.org/10.1155/2022/5089143

Ejemplares similares

Artemether–lumefantrine and dihydroartemisinin–piperaquine treatment outcomes among children infected with uncomplicated Plasmodium falciparum malaria in Mwanza, Tanzania
por: Marwa, Karol J., et al.
Publicado: (2021)

Therapeutic efficacy of artemether-lumefantrine, artesunate-amodiaquine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Sub-Saharan Africa: A systematic review and meta-analysis
por: Marwa, Karol, et al.
Publicado: (2022)

The Influence of Cytochrome P450 Polymorphisms on Pharmacokinetic Profiles and Treatment Outcomes Among Malaria Patients in Sub-Saharan Africa: A Systematic Review
por: Marwa, Karol J, et al.
Publicado: (2023)

Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania
por: Kamugisha, Erasmus, et al.
Publicado: (2012)

Identification of large variation in pfcrt, pfmdr-1 and pfubp-1 markers in Plasmodium falciparum isolates from Ethiopia and Tanzania
por: Golassa, Lemu, et al.
Publicado: (2015)

Self-medication among pregnant women attending antenatal clinic at Makongoro health centre in Mwanza, Tanzania: a challenge to health systems
por: Marwa, Karol J., et al.
Publicado: (2018)

Disposal practices of expired and unused medications among households in Mwanza, Tanzania
por: Marwa, Karol Julius, et al.
Publicado: (2021)

Large differences in variability for genes associated with antimalarial drug resistance between samples from Tanzania and Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2014)

Cytochrome P450 single nucleotide polymorphisms in an indigenous Tanzanian population: a concern about the metabolism of artemisinin-based combinations
por: Marwa, Karol J, et al.
Publicado: (2014)

Prevalence of multiresistant gram-negative organisms in a tertiary hospital in Mwanza, Tanzania
por: Mshana, Stephen E, et al.
Publicado: (2009)

Practice and Knowledge on Type 2 Diabetes Mellitus Risk Factors Among Office Workers in Mwanza City, Tanzania
por: Dika, Haruna, et al.
Publicado: (2023)

Resistance to Cotrimoxazole and Other Antimicrobials among Isolates from HIV/AIDS and Non-HIV/AIDS Patients at Bugando Medical Centre, Mwanza, Tanzania
por: Marwa, Karol J., et al.
Publicado: (2015)

Single dose of gentamicin in combination with metronidazole versus multiple doses for prevention of post-caesarean infection at Bugando Medical Centre in Mwanza, Tanzania: a randomized, equivalence, controlled trial
por: Lyimo, Fadhili M, et al.
Publicado: (2013)

Haptoglobin gene diversity and incidence of uncomplicated malaria among children in Iganga, Uganda
por: Lwanira, Catherine N., et al.
Publicado: (2020)

Prevalence of HIV and associated risk factors among street-connected children in Mwanza city
por: Nyumayo, Said, et al.
Publicado: (2022)

Predictors of positive blood culture and deaths among neonates with suspected neonatal sepsis in a tertiary hospital, Mwanza- Tanzania
por: Kayange, Neema, et al.
Publicado: (2010)

Prevalence and factors associated with severe anaemia amongst under-five children hospitalized at Bugando Medical Centre, Mwanza, Tanzania
por: Simbauranga, Rehema H., et al.
Publicado: (2015)

Efficacy of artesunate-amodiaquine and artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria in Madagascar, 2018
por: Dentinger, Catherine M., et al.
Publicado: (2021)

Microscopic and molecular evidence of the presence of asymptomatic Plasmodium falciparum and Plasmodium vivax infections in an area with low, seasonal and unstable malaria transmission in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2015)

Artemether–lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria
por: Ehrhardt, Stephan, et al.
Publicado: (2009)

Dihydroartemisinin‐piperaquine for treating uncomplicated Plasmodium falciparum malaria
por: Zani, Babalwa, et al.
Publicado: (2014)

Artemisinin‐naphthoquine for treating uncomplicated Plasmodium falciparum malaria
por: Isba, Rachel, et al.
Publicado: (2015)

Human Gene Expression in Uncomplicated Plasmodium falciparum Malaria
por: Colborn, James M., et al.
Publicado: (2015)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2019)

Atovaquone‐proguanil for treating uncomplicated Plasmodium falciparum malaria
por: Blanshard, Andrew, et al.
Publicado: (2021)

Pyronaridine‐artesunate for treating uncomplicated Plasmodium falciparum malaria
por: Pryce, Joseph, et al.
Publicado: (2022)

Complement Activation by Merozoite Antigens of Plasmodium falciparum
por: Korir, Jackson C., et al.
Publicado: (2014)

Detection of a substantial number of sub-microscopic Plasmodium falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2013)

High Affinity Antibodies to Plasmodium falciparum Merozoite Antigens Are Associated with Protection from Malaria
por: Reddy, Sreenivasulu B., et al.
Publicado: (2012)

Inhibition of merozoite invasion and transient de-sequestration by sevuparin in humans with Plasmodium falciparum malaria
por: Leitgeb, Anna M., et al.
Publicado: (2017)

Artesunate plus pyronaridine for treating uncomplicated Plasmodium falciparum malaria
por: Bukirwa, Hasifa, et al.
Publicado: (2014)

Estimation of the In Vivo MIC of Cipargamin in Uncomplicated Plasmodium falciparum Malaria
por: Hien, Tran Tinh, et al.
Publicado: (2017)

Prevalence of polymorphisms in glucose-6-phosphate dehydrogenase, sickle haemoglobin and nitric oxide synthase genes and their relationship with incidence of uncomplicated malaria in Iganga, Uganda
por: Lwanira, Catherine Nassozi, et al.
Publicado: (2017)

High Seroprevalence of SARS-CoV-2 in Mwanza, Northwestern Tanzania: A Population-Based Survey
por: Nyawale, Helmut A., et al.
Publicado: (2022)

Efficient Measurement of Opsonising Antibodies to Plasmodium falciparum Merozoites
por: Hill, Danika L., et al.
Publicado: (2012)

Hyperparasitaemia during clinical malaria episodes in infants aged 0–24 months and its association with in utero exposure to Plasmodium falciparum
por: Sylvester, Boniphace, et al.
Publicado: (2018)

High prevalence and extended deletions in Plasmodium falciparum hrp2/3 genomic loci in Ethiopia
por: Golassa, Lemu, et al.
Publicado: (2020)

Exploration of in vivo efficacy of artemether-lumefantrine against uncomplicated Plasmodium falciparum malaria in under fives in Tabora region, Tanzania
por: Joseph, Deokary, et al.
Publicado: (2013)

Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania
por: Mhamilawa, Lwidiko E., et al.
Publicado: (2020)

Plasmodium falciparum Merozoite Associated Armadillo Protein (PfMAAP) Is Apically Localized in Free Merozoites and Antibodies Are Associated With Reduced Risk of Malaria
por: Aniweh, Yaw, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_knf7p2ar8c0nusmlru40iu1h52